Position in GILD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$243,758
+$29,086 QoQ
Shares Held
1,749
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Athena Investment Management holds $8,014,106 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,063 | $2,280,613 | |
| 2 | JNJ |
Johnson & Johnson
|
5,245 | $1,332,072 | |
| 3 | LLY |
ELI LILLY & Co
|
831 | $996,726 | |
| 4 | PFE |
Pfizer Inc
|
41,018 | $987,713 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,598 | $976,343 | |
| 6 | AMGN |
Amgen Inc
|
2,236 | $809,700 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,950 | $630,939 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243,758 | 1,749 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $214,672 | 1,749 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||